Literature DB >> 18336997

The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.

S G Reeves1, D Mossman, C J Meldrum, G Kurzawski, J Suchy, J Lubinski, R J Scott.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited syndrome caused by germline mutations in mismatch repair (MMR) genes. HNPCC patients have a lifetime risk of 80% of developing colorectal cancer (CRC); however the likely age of onset is difficult to predict. A single C>T polymorphism located within the promoter region of the DeltaDNMT3B gene has recently been reported to be associated with a significant increase to the risk of early onset CRC. In this study we determined the DeltaDNMT3B genotype in 404 confirmed HNPCC participants (total of 194 CRC cases) from Australia (203) and Poland (201). From the total number of participants there were 194 diagnosed cases of CRC and 210 healthy MMR gene mutation carriers. The study was undertaken to assess whether the reported effect observed in a previous study of 146 HNPCC patients is consistent in a larger separate and unrelated participant cohort. Through the statistical tests of Kaplan-Meier survival analysis and Cox hazard regression models we did not observe any significant association between the DeltaDNMT3B C>T SNP and early onset CRC in HNPCC patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336997     DOI: 10.1016/j.canlet.2008.02.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  DNMT3B polymorphisms and cancer risk: a meta analysis of 24 case-control studies.

Authors:  Shimiao Zhu; Hui Zhang; Yang Tang; Peicai Liu; Jianmin Wang
Journal:  Mol Biol Rep       Date:  2011-09-22       Impact factor: 2.316

2.  Genetic polymorphism of DNA methyltransferase 3B 149 C>T and risk of colorectal cancer: a meta-analysis.

Authors:  Qingkai Meng; Jingru Zhang; Bo Lian; Chun Song
Journal:  Tumour Biol       Date:  2013-11-01

Review 3.  Systematic evaluation of cancer risk associated with DNMT3B polymorphisms.

Authors:  Fujiao Duan; Shuli Cui; Chunhua Song; Liping Dai; Xia Zhao; Xiaoqin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-11       Impact factor: 4.553

4.  Association of DNMT3B -283 T > C and -579 G > T polymorphisms with decreased cancer risk: evidence from a meta-analysis.

Authors:  Yang Zhang; Haisheng Xu; Yi Shen; Zhimin Gong; Tianlin Xiao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis.

Authors:  Jing Zhu; Songtao Du; Jiaqi Zhang; Yingnan Wang; Qiaoling Wu; Jixiang Ni
Journal:  Med Oncol       Date:  2014-11-30       Impact factor: 3.064

6.  The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies.

Authors:  Chunyan Fang; Wenqi Sun; Huirong Han; Lihong Shi; Lin Wang; Yan Zhao; Yang Tan
Journal:  Exp Ther Med       Date:  2012-07-17       Impact factor: 2.447

Review 7.  Genetic modifiers of cancer risk in Lynch syndrome: a review.

Authors:  Bente A Talseth-Palmer; Juul T Wijnen; Desma M Grice; Rodney J Scott
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.